Use of non-error-propagating phasing techniques and combination of allelic balance to improve cnv detection
AssigneeMyome, Inc.
InventorsAKASH KUMAR, MATTHEW RABINOWITZ
Life of this patent
Estimating the term…
Loading patent…
AssigneeMyome, Inc.
InventorsAKASH KUMAR, MATTHEW RABINOWITZ
Estimating the term…
Disclosed herein are methods of using non-error-propagating phasing techniques in combination with sequencing data obtained through more conventional error-propagating approaches to improve phasing of a genome and correct allele balance signals, which may allow for improved determinations of ploidy status of chromosomal segments. Further disclosed herein are methods of using allele balance and depth of read in combination to make improved ploidy status determinations. The techniques described herein may be used in a minimally invasive manner to make ploidy status determinations for an embryo or fetus and to identify chromosomal instability in tumor DNA.
A method of correcting an allele balance signal for a chromosomal segment, the method comprising:
The method of any one of the preceding claims, wherein obtaining the allele balance signal comprises performing the sequencing on the sample of genetic material.
The method of any one of the preceding claims, wherein the allele balance signal and the plurality of reads are derived from the same sample of genetic material, optionally wherein the sample is a body fluid sample (e.g., a blood sample, a saliva sample) or a tissue biopsy sample, further optionally wherein the allele balance signal and the plurality of reads are derived from a same population of cells.
The method of any one of the preceding claims, wherein the allele balance signal is derived from cell-free DNA and the plurality of reads are derived from cellular DNA, optionally wherein the cellular DNA is from cells found within a body fluid (e.g., blood or saliva).
The method of any one of the preceding claims, wherein the reference genetic code is derived from the sequencing used to generate the allele balance signal.
The method of any one of the preceding claims, wherein the reference genetic code is derived, at least in part, from sequencing of normal tissue in a subject for which the allele balance signal is obtained.
The method of any one of the preceding claims, wherein the reference genetic code is derived, at least in part, from sequencing of germline tissue in a subject for which the allele balance signal is obtained.
The method of any one of the preceding claims, wherein the reference genetic code is derived, at least in part, from sequencing genetic material from one or more genetic relatives of a subject for which the allele balance signal is obtained.
The method of any one of the preceding claims, wherein the reference genetic code is derived, at least in part, from whole genome shotgun sequencing of a subject for which the allele balance signal is obtained.
The method of any one of the preceding claims, wherein the non-error-propagating technique comprises single cell sequencing.
The method of any one of the preceding claims, further comprising collecting a sample of genetic material from which the allele balance signal is derived.
The method of any one of the preceding claims, further comprising collecting a sample of genetic material from which the plurality of reads are derived.
The method of any one of the preceding claims, wherein correcting the allele balance data comprises correcting a switch error in the at least partially phased reference genetic code.
The method of any one of the preceding claims, wherein the allele balance signal is averaged over a plurality of binned variants within a region of at least about 50,000, 100,000, 200,000, 300,000, 400,000, 500,000, 750,000, 1,000,000, 50,000,000, or 100,000,000 bp.
The method of any one of the preceding claims, wherein the allele balance signal is averaged over a plurality of binned variants within a region of no greater than about 50,000, 100,000, 200,000, 300,000, 400,000, 500,000, 750,000, 1,000,000, 50,000,000, or 100,000,000 bp.
The method of any one of the preceding claims, wherein the allele balance is averaged over a haplotype block.
The method of any one of the preceding claims, wherein the allele balance signal is filtered for a minimum read depth, optionally wherein the minimum read depth is 5, 10, 15, 20, or 25 reads.
The method of any one of the preceding claims, wherein the two phase sets are neighboring phase sets within the reference genetic code.
The method of any one of the preceding claims, wherein the plurality of reads are filtered for reads comprising at least 2, 3, 4, or 5 of the variants of interest from each of the two phase sets.
The method of any one of the preceding claims, further comprising using the corrected allele balance signal to determine a ploidy status for a chromosomal segment, optionally wherein determining the ploidy status comprises calling a copy number variant (CNV).
A method of determining a ploidy status for a chromosomal segment, the method comprising:
The method of any one of the preceding claims, wherein the method comprises obtaining a signal indicative of ploidy status (e.g., the allele balance signal or depth of read signal) that is derived from a sample comprising a population of cells having different copy numbers for the chromosomal segment, optionally wherein some cells have an aneuploidy and others do not.
The method of any one of the preceding claims, wherein the method comprises obtaining a signal indicative of ploidy status (e.g., the allele balance signal or depth of read signal) that is derived from a sample comprising one or more tumor cells.
The method of any one of the preceding claims, wherein the method comprises obtaining a signal indicative of ploidy status (e.g., the allele balance signal or depth of read signal) that is derived cell-free DNA, optionally wherein the cell-free DNA comprises cell-free fetal DNA (cffDNA) or circulating tumor DNA (ctDNA).
The method of any one of the preceding claims, wherein the method comprises obtaining a signal indicative of ploidy status (e.g., the allele balance signal or depth of read signal) that is derived from an embryo, optionally prior to implantation of the embryo into a womb.
The method of any one of the preceding claims, wherein the method comprises obtaining a signal indicative of ploidy status (e.g., the allele balance signal or depth of read signal) that is derived from a fetus.
A method of phasing a germline mosaic variant in a subject, the method
Dependencies are inferred from the claim text.